Vanda Pharmaceuticals Inc.
USD5.87
-0.23 (-3.77%)
CEO
Mihael H. Polymeropoulos
IPO Date
2006-04-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.09
Prev. Close
$6.10
Day Low
$5.87
Day High
$6.14
52W Low
$4.14
52W High
$9.94
Market Cap
$0.35B
Volume
1.32M
| 41,600 |
| $0.00 |
| 8 Jun 2026 | Duncan Charles Cliff | director | A-Award | Acquired | 41,600 | $0.00 |
| 8 Jun 2026 | DUGAN RICHARD W | director | A-Award | Acquired | 41,600 | $0.00 |
| 8 Jun 2026 | Ward Anne Sempowski | director | A-Award | Acquired | 41,600 | $0.00 |
| 8 Jun 2026 | Honore Tage | director | A-Award | Acquired | 41,600 | $0.00 |
| 8 Jun 2026 | Mitchell Stephen Ray | director | A-Award | Acquired | 41,600 | $0.00 |
| 8 Jun 2026 | McGuire Daniel Patrick | SVP, GC and Secretary | Disposed | 0 | $0.00 |
| 8 Jun 2026 | McGuire Daniel Patrick | SVP, GC and Secretary | Disposed | 0 | $0.00 |
| 8 Jun 2026 | McGuire Daniel Patrick | SVP, GC and Secretary | Disposed | 0 | $0.00 |